Sort
48,018 grants matching “immunotherapy”
Targeting colorectal cancer stem cells with ALDH1B1 antagonists
$418,307James K Chen · Stanford University · R01 · FY2024 · CA
A Phase I Study of Lentivirus Safety During T-Cell Immunotherapy
$418,285John A Zaia · Beckman Research Institute/City Of Hope · P01 · FY2007 · AI
BOSTON AIDS MALIGNANCY CONSORTIUM
$418,282Massachusetts General Hospital · U01 · FY2003 · CA
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$418,234Melody A Swartz · University Of Chicago · R01 · FY2024 · CA
Cockroach and mouse allergy T cell phenotypes and their correlation with clinical status
$418,205Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2021 · AI
IN VITRO STUDIES OF HUMAN ANAPHYLAXIS
$418,202Johns Hopkins University · R01 · FY2001 · AI
BET degraders for improving colorectal cancer therapy
$418,169Lin Zhang · University Of Southern California · R01 · FY2023 · CA
Core D: Long-Term Follow-Up
$418,106Stephanie J Lee · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Core D: Long-Term Follow-Up
$418,106Stephanie J Lee · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Immunobiology of Myeloid and Lymphoid Cells
$418,091William R Green · Dartmouth College · T32 · FY2006 · AI
Transport Oncophysics Core
$418,062Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2017 · CA
VIRULENCE AND IMMUNITY TO STAPHYLOCOCCI
$418,058Brigham And Women'S Hospital · R21 · FY2000 · AI
Spatial and Temporal Progression of Amyloid Angiopathy
$418,048Matthew P Frosch · Massachusetts General Hospital · R01 · FY2010 · AG
Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
$418,039William J Aronson · University Of California Los Angeles · R01 · FY2019 · CA
Neutrophils and Monocytes in Pediatric Ischemic Stroke
$418,019Chia-Yi Kuan · University Of Virginia · R01 · FY2024 · NS
An in vivo CRISPR-Cas9 genetic screen in murine primary T cells to discover metabolic regulators of follicular B helper T (Tfh) cell differentiation
$417,953Joseph E Craft · Yale University · R33 · FY2019 · AR
Project 4: Using Synthetic Immunology to Improve Activity and Specificity, and Overcome Resistance, in Cellular Therapy
$417,945David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2022 · CA
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$417,934Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2018 · CA
Role of KAT5 in lung cancer
$417,904Susumu Kobayashi · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Protection of the Heart by PD-1 and PD-L1
$417,886Andrew H Lichtman · Brigham And Women'S Hospital · R01 · FY2015 · HL
Functional Activation of Low Affinity TILs
$417,867Jill E Slansky · University Of Colorado Denver · R01 · FY2020 · CA
Core D: Long-term Follow-Up
$417,866Stephanie J Lee · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Basophil phenotype & activation in peanut allergy and oral Immunotherapy
$417,807Stephen J Galli · Stanford University · U19 · FY2013 · AI
Evaluation of Immune-based Combinations in Prostate Cancer
$417,740Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Nanocage-based systemic delivery of TGFb trap for immunomodulation of brain neoplasms
$417,726Jung Soo Suk · University Of Maryland Baltimore · R01 · FY2025 · NS